S. Korea Scientists Identify Liver Cancer Gene, Develop Drugs
This article was originally published in PharmAsia News
South Korean researchers report discovery of the gene responsible for causing liver cancer. The team of university researchers said they developed a chemical compound capable of targeting the TM4SFS gene and keeping it from growing out of control. An announcement by the researchers said they are looking for a business partner to conduct clinical trials on the drugs. (Click here for more
You may also be interested in...
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.
The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.